DWTX - Dogwood Therapeutics, Inc.
4.63
0.110 2.376%
Share volume: 222,603
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$4.52
0.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 1.314 M | 1.070 M | 2.301 M | |
| Selling general and admin | 970.384 K | 733.740 K | 1.766 M | |
| Research and development | 343.717 K | 336.084 K | 535.162 K | |
| Total expenses | 1.314 M | 1.070 M | 2.301 M | |
| -18.59% | 115.10% | |||
| Operating income | -1.314 M | -1.070 M | -2.301 M | |
| Ebit | -1.314 M | -1.070 M | -2.281 M | |
| Pretax income | -1.291 M | -1.050 M | -2.281 M | |
| -18.70% | 117.24% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.291 M | -1.050 M | -2.281 M | |
| 18.70% | -117.24% |
